X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BIVI

Closed

Biovie Inc

0.931
+0.006 (+0.65%)
Last Update: 01 Jul 2025 23:05:00
Yesterday: 0.925
Day's Range: 0.88 - 0.96
Send
When Written:
 
8.08
Biovie Inc. is a clinical-stage biotechnology company that is focused on developing and commercializing innovative drug therapies for rare and orphan diseases. The company's lead drug candidate is BIV201, which is being developed for the treatment of refractory hypotension, a life-threatening condition that affects patients with severe sepsis and septic shock. Biovie is also developing other drug candidates for the treatment of rare and orphan diseases, including pulmonary arterial hypertension and acute respiratory distress syndrome. The company is headquartered in Beverly, Massachusetts, and was founded in 2010.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X